panitumumab,bevacizumab
amgen,roche
['rectal', 'colorectal', 'bevacizumab', 'panitumumab']
panitumumab vs bevacizumab added to standard first-line chemotherapy and overall survival among patients with ras wild-type, left-sided metastatic colorectal cancer: a randomized clinical trial, from , free to read online during #asco23. 
JAMA is an international peer-reviewed general medical journal published weekly online and in print, and a member of the @JAMANetwork family of journals.